Starting colonoscopy surveillance at the age of 25 years rather than at 20 years in patients with Lynch syndrome and MLH1 or MSH2 as the causative gene and at the age of 35 or 40 years for those with MSH6 or PMS2 as the causative gene is more cost-effective. This evidence concerns the gene MSH6 and Lynch syndrome.